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Summary
The enzyme RedP is thought to initiate the biosynthe-
sis of the undecylpyrolle component of the antibiotic
undecylprodiginine produced by Streptomyces coeli-
color. RedP has homology to FabH, which initiates
fatty acid biosynthesis by condensing the appropriate
acyl-CoA starter unit with malonyl ACP. We have gen-
erated a redP-deletion mutant of S. coelicolor M511
(SJM1) and shown that it produces reduced levels of
prodiginines and two new analogs, methylundecylpro-
diginine and methyldodecylprodiginine. Incorporation
studies with perdeuterated valine were consistent with
these being generated using methylbutyryl-CoA and
isobutyryl-CoA as starter units, respectively. Plasmid-
based expression of a streptomycete fabH in the
SJM1 mutant led to restoration of overall prodiginine
titers but the same overall ratio of undecylprodigi-
nines and novel prodiginines. Thus, the redP FabH
can be replaced by FabH enzymes with different sub-
strate specificities and provides a method for gener-
ating novel prodiginines.
Introduction
Actinomycetes and other eubacteria produce alkyl-
prodiginines (prodigiosins), a family of red-pigmented
antibiotics [1]. The chemical composition of “prodigio-
sin” was established over 40 years ago, and it seems
possible that by virtue of their color, these types of
compounds may have been observed for centuries [2].
These antibiotics have a broad range of activity against
bacteria, protozoa, and pathogenic fungi, but are not
used clinically because of their toxicity [2, 3]. Interest
in clinical development of prodiginine-type drugs as an-
titumor agents and immunosuppressants has been
stimulated in recent years by a number of factors. It
has been shown that they have immunosuppressive ac-
tivity at noncytotoxic doses and operate by a different
mechanism of action than either cyclosporine and
FK506 (coadministration consequently gives a syner-
gistic effect on the immune system) [2]. Numerous pro-
diginine and related compounds (including roseophilin)
[4] have also been shown to have potent apoptotic ef-
fects on human cancer cells [5, 6]. More recently, syn-
thetic efforts have made it possible to generate new
prodiginine analogs with improved therapeutic indices
[2, 5].*Correspondence: kareynol@hsc.vcu.eduIn addition to ongoing synthetic efforts, a genetic and
biochemical understanding of prodiginine biosynthesis
has begun to emerge [3]. This work has provided the
basis for rational approaches to engineer the biosyn-
thesis of novel prodiginines, potentially with improved
immunosuppressant or antitumor activities. Undecyl-
prodiginine (Figure 1) is the most well studied of this
structural class of compounds, and labeling studies
have shown that it is generated from multiple acetate
units as well as one unit each of proline, glycine, and
serine [7–9]. This and its oxidatively cyclized form, bu-
tyl-meta-cycloheptylprodiginine, have been shown to
be the principal components of the red-pigmented anti-
biotics produced by Streptomyces coelicolor A3(2) [10].
The recently completed S. coelicolor genome se-
quence has provided the entire red biosynthetic gene
cluster [11]. A subsequent analysis of this cluster has
resulted in proposed assignments for most of these
genes in prodiginine biosynthesis [3].
Prodiginines are assembled by a convergent process
involving a late-stage condensation of 2-undecylpyr-
role (Figure 1) with 4-methoxy-2,2#-bipyrrole-5-carbal-
dehyde. It has been proposed that this unit is derived
from the condensation of β-ketomyristoyl thioester with
glycine, with concomitant loss of carbon dioxide from
the latter [9]. Eight of the 23 genes in the cluster (redX,
redR, redQ, redP, redN, redH, redG, and redF) have been
proposed to be involved in formation of the 2-unde-
cylpyrrole [3]. Of these, redP, redR, and redQ encode
homologs of FabH (KASIII) and FabF (KASII) enzymes
and an acyl carrier protein (ACP), respectively [3], com-
ponents of the type II dissociated fatty acid synthase
(FAS) in streptomycetes, Escherichia coli, and other mi-
croorganisms [12–15]. RedP is proposed to initiate the
biosynthetic process by condensing an acetyl CoA
starter unit with malonyl ACP (RedQ) [3] (Figure 1). The
3-keto group of the resulting acetoacyl thioester would
be reduced to provide butyryl ACP, presumably by the
appropriate type II FAS enzymes [3]. The redR-encoded
FabF homolog might catalyze four subsequent elonga-
tion steps with malonyl ACP (RedQ), with appropriate
3-keto group processing after each step. The resulting
dodecyl ACP (RedQ) is the proposed substrate for the
unusual PKS encoded by redX, which generates the
β-ketomyristoyl thioester using a malonyl extender unit
bound to an ACP domain in the redN gene product [3]
(Figure 1).
Evidence in the last few years has established that
ketoacyl ACP synthases (KASs) involved in both FAS
and PKS processes can exhibit significant ACP specifi-
cities, which enables these two processes to function
independently [16]. In particular, it has been shown that
the FabH, which initiates fatty acid biosynthesis in
streptomycetes, reacts only with FAS ACPs and not
ACPs from type II aromatic polyketide synthetic pro-
cesses [16]. Thus, a FAS-type process which needs to
interact with PKS must involve a specific set of KAS
enzymes along with a dedicated ACP [17], as in the
case of the proposed formation of the dodecyl ACP
substrate for prodiginine biosynthesis. Nonetheless,
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192Figure 1. Proposed Roles of RedP and a FAS FabH in Initiating Alkylprodiginine Biosynthesis
Butyl-meta-cycloheptylprodiginine, undecylprodiginine [R1 = CH2CH3], methylundecylprodiginine [R1 = CH(CH3)2)], and methyldodecyl-
prodiginine [R1 = CH2CH(CH3)2]. Biosynthesis of the known prodiginines from an acetyl CoA starter unit (R = CH3) can be accomplished with
either RedP or FabH and six elongation steps by RedR. Biosynthesis of the latter two novel branched-chain alkylprodiginines from 3-methylbutyryl
CoA [R = CH2CH(CH3)2] and isobutyryl CoA [R = CH(CH3)2] can only be observed when initiation is from FabH and involves five or six
elongation steps by RedR, respectively. The ACP encoded by redQ is proposed to be involved in all the initial steps of the pathway.the role of these enzymes and the absolute requirement b
pfor them has not been investigated. In this work, we
ahave shown through genetic studies that the redP FabH
1product plays an important but not essential role in un-
Sdecylprodiginine biosynthesis. Furthermore, we have
lprovided, to the best of our knowledge, the first exam-
nple of bioengineering of branched-chain alkylprodigi-
tnines by replacement of the RedP function with a strep-
stomycete FAS FabH. Finally, we have shown that even
swhen a streptomycetes FAS FabH initiates both fatty
aacid biosynthesis and prodiginine biosynthesis, the ra-
gtio of straight and branched-chain components of each
tis distinctly different. This last observation suggests
(that there is additional selectivity beyond the initiation
tstep of these two processes.
a
n
Results o
H
Deletion of redP in S. coelicolor Leads to a Decrease d
in Prodiginine Production in R2YE Media f
The redP gene encodes a homolog of the E. coli FabH l
enzyme and was identified in the sc3F7 cosmid by the 9
hS. coelicolor genome sequencing project [11]. It haseen proposed that this gene product could initiate
rodiginine biosynthesis by catalyzing formation of an
cetoacetyl ACP from an acetyl CoA starter unit (Figure
) [3]. To test this hypothesis, we generated a new
JM1 mutant by replacing the redP gene in S. coelico-
or M511 (a mutant which produces prodiginines but
ot actinorhodin) with the ApraR-oriT cassette, using
he recently described PCR-targeted gene replacement
trategy developed for Streptomyces [18]. In R2YE
olid medium, the S. coelicolor M511 and SJM1 grew
nd sporulated normally. The SJM1 also appeared to
enerate some level of a red-pigmented product, al-
hough at apparently lower levels than the M511 strain
Figure 2). To quantitate the effect of loss of redP, the
wo mutants were grown for 10 days in liquid culture
nd analyzed for both cell growth and overall prodigi-
ine production. As shown in Figure 3, there was no
bservable difference in the growth of either strain.
owever, in the SJM1 strain, the maximal levels of pro-
iginines were at least 4-fold lower than that observed
or the parent M511 strain. In both cases, the maximal
evels of prodiginines were observed at approximately
6 hr. In neither case did continued incubation lead to
igher levels.
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193Figure 2. Growth of S. coelicolor M511 and SJM1 in R2YE Agar
Plate after 5 Days of Incubation at 30°CLC-MS Analysis of Prodiginine Production
in S. coelicolor SJM1 and M511
HPLC analyses of the M511 (Figure 4A) and SJM1 mu-
tant (Figure 4B) and the corresponding pSE34 trans-
formants (a Streptomyces expression plasmid) were
carried out using both mass spectrometry and absor-
bance (530 nm) as detection methods. In all cases, the
major prodiginine product eluted at 24 min (the levels
of this were significantly higher in the M511 mutant).
Mass spectrometry analysis demonstrated a parent ion
[M+H]+ with an m/z value of 394 (Figure 5A), consistent
with the structure of undecylprodiginine. A smaller peak
eluting slightly earlier was also consistently observed,
and mass spectral analysis (m/z 392) indicated that this
was likely the oxidatively cyclized product, butyl-meta-
cycloheptylprodiginine. These observations are similar
to those made previously made for S. coelicolor, where
these two compounds have been shown to be the ma- of at least two separate compounds. Mass spectral
Figure 3. Growth and Prodiginine Production
of M511 and SJM1 Strains in Liquid R2YE
Medium
Production was measured in acidified meth-
anol at 530 nm.Figure 4. HPLC Analyses of Alkylprodiginine Production by S. coeli-
color
(A), (B), and (C) are from S. coelicolor M511, SJM1, and SJM1/
pSW7, respectively. Prodiginines were resolved by reverse-phase
HPLC and detected by both absorbance at 530 nm (data shown)
as well as mass spectral analysis. I, undecylprodiginine; II,
methylundecylprodiginine; III, methyldodecylprodiginine.jor prodiginines [10]. In the case of the S. coelicolor
SJM1, lower levels of new prodiginines eluting with
slightly longer retention times were observed by both
absorbance and mass spectral analyses (see Figure
4B). These new prodiginines appeared to be composed
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194Figure 5. Mass Spectral Analysis of Prodiginines in the S. coelicolor SJM1 Mutant
(A) Undecylprodiginine with an m/z of 394.
(B) Methylundecylprodiginine with an m/z of 408.
(C) Methyldodecylprodiginine with an m/z of 422.analysis revealed parent ions [M+H]+ with m/z values of a
t408 and 422 (Figures 5B and 5C) for peaks eluting at
24.4 and 25.2 min, respectively. These masses are 14 p
Rand 28 AMU higher than the mass of the undecylprodi-
ginine parent ion, indicating the presence of novel pro- t
bdiginines containing longer (C12 and C13) alkyl chains.
HRFAB-MS was obtained for each of these peaks. The z
lfirst peak had pseudomolecular ions observed at m/z
394.2840 and 394.2839 [M+H]+ in agreement with the T
aC25H35N3O molecular formula for undecylprodiginine
(m/z 394.2859, [M+H]+ calc.). The second peak had t
ipseudomolecular ions observed at m/z 408.3001 and
408.3010 [M+H]+ in agreement with the proposed s
cC26H37N3O molecular formula for (m/z 408.3016, [M+H]+
calc.). The final peak had pseudomolecular ions ob- P
Fserved at m/z 422.3171 and 422.3174 [M+H]+ in
agreement with the proposed C27H39N3O molecular for- c
emula (m/z 422.3172, [M+H]+ calc.). These compounds
were consistently observed in the S. coelicolor SJM1 g
amutant and were not detected under the growth and
analytical conditions used (including use of single-ion b
amonitoring) with the S. coelicolor M511.
Low-level prodiginine production in the SJM1 mutant c
gindicted that, while RedP is important in biosynthesis,
its function can be replaced, albeit less efficiently, by 4n alternative enzyme or pathway. One candidate was
he S. coelicolor fatty acid synthase (FabH), which is
resumed to have different substrate specificities to
edP but catalyzes the same type of reaction (elonga-
ion of an acyl CoA primer with malonyl ACP). It has
een shown previously that fatty acid biosynthetic en-
ymes, including FabH, are active during and after late
og-phase growth, when antibitoics are produced [16].
he streptomycetes FabH has also been shown to have
relaxed acyl-group substrate specificity compared to
he E. coli FabH enzyme and appears to be able to use
sobutyryl CoA and even methylbutyryl CoA as sub-
trates, thus allowing production of both branched-
hain fatty acids and straight-chain fatty acids [19].
riming of prodiginine biosynthesis by the S. coelicolor
abH might thus account for the production of branched-
hain alkyl analogs. Use of methylbutyryl CoA with five
longation steps (carried out by FabH and RedR) would
enerate a ω-2 methyldodecoyl ACP product (Figure 1)
nd ultimately a methylundecylprodiginine. Use of an iso-
utyryl CoA starter and six elongation steps would provide
ω-2 methyltridecoyl ACP and ultimately a methyldode-
ylprodiginine. These two novel branched-chain prodi-
inines would have masses [M+H]+ of 408.3016 and
22.3172, as observed in the analyses of SJM1 mutant.
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poration studies with perdeutreated-labeled valine were
used to confirm that a FAS FabH initiates prodiginine
biosynthesis in the SJM1 mutant, leading to the gener-
ation of novel branched-alkyl-chain prodiginines.
Complementation of S. coelicolor SJM1
A complementation experiment in SJM1 using pKR3, a
RedP expression plasmid, was carried out. This plas-
mid led to a 3-fold increase in the levels of prodiginines
relative to SJM1 carrying a control plasmid (Table 1). A
complementation experiment carried out using pSW7
for expression of Streptomyces glaucenscens FAS
FabH (which has very high sequence identity to the
S. coelicolor FabH) led to almost a 4-fold increase in
overall prodiginine levels in the SJM1 mutant. These
levels were close to that observed for the M511 strain.
In contrast to these results, there were smaller in-
creases in prodiginine production using the E. coli
FabH expression plasmid, pSE4 (Table 1). LC analyses
of prodiginine analogs produced by these complemen-
tation experiments in the SJM1 mutant were carried
out. This analysis of the SJM1/pSW7 mutant revealed
that, while there was an increase in the levels of all of
the prodiginines produced by the SJM1 mutant, the ra-
tio of the various analogs was unchanged (Figures 4C
and 6B). In contrast, the levels of these new prodigi-
nines, relative to undecylprodiginine, decreased in the
SJM1 mutant with expression of either the RedP or
E. coli FAS FabH. These observations clearly demon-
strated that the Streptomyces FAS FabH can initiate
prodiginine biosynthesis in the absence of RedP and
apparently does so using at least three different
starter units.
Relative FabH Activity Levels in Cell Extracts
of SJM1 and M511
Support for the role of the FAS FabH initiating prodigi-
nine biosynthesis in the SJM1 mutant was provided
through FabH assays of cell extracts of both this strain
and M511. The RedQ ACP encoded by the prodiginine
biosynthetic gene cluster, the proposed substrate for
RedP (Figure 1), was used for these assays and was
expressed in E. coli as an N-terminal His-tagged pro-
tein in predominantly the holo form (>95%). Cell ex-
tracts of the SJM1 mutant strain exhibited approxi-
mately 10% of the corresponding activity of extracts of
M511 strain, indicating that RedP present in the latterTable 1. Prodiginine Production and FabH Activity of S. coelicolor M511 and SJM1
Strain Overall Prodiginine Levels (%) Ratio of Prodiginines (I:II:III)a FabH Activity of Cell Extractb (cpm)
M511/pSE34 100 (±7) 100 (±2):0:0 1700 (±200)
SJM1/pSE34 20 (±1) 21 (±2):2 (±1):1 (±1) 150 (±50)
SJM1/pSW7 78 (±3) 63 (±1):5 (±2):4.5 (±2) 2700 (±200)
SJM1/pSW7+valine — 75 (±2):3 (±3):6 (±2) —
SJM1/pSE4 33 (±2) — 630 (±100)
SJM1/pKR3 67 (±1) — 1590 (±200)
a The ratios of undecylprodiginine (I), methylundecylprodiginine (II), and methyldodecylprodiginine (III) are expressed as a percentage of the
overall prodiginine levels made in M511/pSE34. pSE34 is the control plasmid and was used to generate pSW7 (containing the S. glaucescens
FAS fabH), pSE4 (containing the E. coli FAS fabH), and pKR3 (containing the S. coelicolor redP).
b Results from one set of FabH assays were conducted in duplicate on each cell extract containing equivalent protein content. Additional
analyses provided different absolute values but the same ratio of activities.strain is responsible for the majority of FabH activity
with RedQ ACP as substrate (Table 1). The drop in ac-
tivity correlated closely with the decreased level of
prodiginine production. Cell extracts prepared from
SJM1 containing either the pSW7 (for expression of the
S. glaucescens FAS FabH) or pKR3 (plasmid-based ex-
pression of RedP) exhibited at least the same levels of
FabH activity as did extracts of M511. These observa-
tions, along with the partial restoration of prodiginine
levels (Table 1 and Figure 6B), demonstrated expres-
sion of both of these proteins. Furthermore, the
increase in FabH activity in SJM1/pSW7 relative to
SJM1 is consistent with the proposal that a streptomy-
cete FAS FabH can utilize the RedQ substrate and is
likely responsible for the low-level FabH activity and
prodiginine production associated with the SJM1 mu-
tant. FabH activity levels in cell extracts of SJM1/pSE4
increased only slightly over that observed for the SJM1
(Table 1) and corresponded with the slight increase in
prodiginine levels observed for complementation ex-
periments using the E. coli FabH.
Incorporation Studies with Perdeutrated DL-Valine
Incorporation experiments with perdeutrated DL-valine
demonstrated that the new prodiginines made in the
SJM1 mutant likely contain branched alkyl chains. Effi-
cient labeling of BCFAs by perdeuterated valine has
previously been demonstrated [20]. In this case, valine
is degraded to perdeutrated isobutyryl CoA, which is
subsequently used to make even-numbered BCFAs,
labeled intact with seven deuteriums. The first inter-
mediate in this degradation pathway, α-ketoisovaleryl
CoA, is an intermediate in leucine biosynthesis. Degra-
dation of leucine provides 3-methylbutyryl CoA for the
biosynthesis of odd-numbered BCFAs containing an
ω-2 methyl group. These fatty acids are also labeled
intact with seven deuteriums with perdeutrated valine
incorporation studies, albeit to a lesser degree [20].
Similar observations to these were made with prodigi-
nines made in the SJM1 mutant.
Mass spectral analyses of prodiginines isolated from
an incorporation study on S. coelicolor SJM1/pSW7
showed an efficient (66%) labeling of the putative iso-
butyryl CoA-derived prodiginines, methyldodecylprodi-
ginine, with seven deuteriums (masses 429 and 422 in
Figure 6Ab). Less efficient labeling (33%) with seven
deuteriums was observed for the putative methylbu-
tyryl CoA-derived prodiginine, methylundecylprodigi-
Chemistry & Biology
196Figure 6. A Perdeuterated (D8) Valine Feeding Study in the S. coelicolor SJM1 and SJM1/pSW7
(A) MS analysis of the SJM1/pSW7 reveals an efficient and predictable deuterium labeling (M+7) for the isobutyrate-derived (b) and methylbu-
tyrate-derived branched-chain alkylprodiginines (c). No significant labeling was observed for the normal acetate-derived undecylprodigi-
nine (a).
(B) Production of novel prodiginine analogs (yellow and green bars) was observed only in SJM1 mutant, and their ratio relative to undecylprodi-
ginine did not alter with either expression of the S. glaucescens FabH (encoded by pSW7) or the addition of valine.nine (masses of 415 and 408 in Figure 6Ac). This latter s
tresult provides compelling evidence that these prodigi-
nines are produced by the leucine catabolite 3-methyl-
mbutyryl CoA. It is not possible to determine from these
experiments if the isoleucine catabolite 2-methylbutyryl r
tCoA is also used. In contrast to these observations,
there was no significant deuterium labeling of the unde- f
gcylprodiginine in the perdeuterated valine incorporationtudy (mass of 394 only in Figure 6Aa), consistent with
he use of an acetyl CoA starter unit.
It has been demonstrated previously that in Strepto-
yces the addition of valine dramatically increases the
elative levels of isobutyryl CoA-derived BCFA relative
o other fatty acids [19]. Addition of valine might there-
ore also increase the levels of the methyldodecylprodi-
inine relative to the other prodiginines. This possibility
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of the various prodiginines in fermentations of the S. coe-
licolor SJM1/pSW7 in the presence and absence of va-
line. As shown in Figure 6B, branched-chain alkylprodi-
ginines comprise approximately 16% of the overall
prodiginine pool in SJM1 and SJM1/pSW7. In the pres-
ence of valine, this ratio does not increase. A small
increase in the ratio of the methyldodecylprodiginine
relative to the methylundecylprodiginine was observed.
The low-level production of these prodiginines makes
it difficult determine if this change is statistically signifi-
cant. Analyses of the fatty acid pools generated under
these conditions revealed that approximately 85% were
BCFAs. Thus, the FAS FabH appears to use the same
precursors to initiate fatty acid and prodiginine biosyn-
thesis in the SJM1 mutant, yet the ratios of the product
analogs in these two processes vary dramatically.
Discussion
It has been known for some time that initiation of fatty
acid biosynthesis in a type II FAS is catalyzed by FabH
[21] and that the acyl group specificity of this enzyme
is likely a contributing factor in the type of fatty acids
made by an organism [19, 22–26]. The catalytic steps
involved in polyketide biosynthetic processes are anal-
ogous to those of fatty acid biosynthesis but use a
more diverse range of initiation mechanisms [27, 28]. A
limited but growing number of polyketide biosynthetic
gene clusters contain genes encoding FabH homologs,
indicating that, at least in some cases, the FAS and
polyketide biosynthetic processes initiate via a similar
mechanism [17, 29–32]. In vitro characterization of two
of these enzymes, DpsC and ZhuG, has demonstrated
that they exhibit the predicted catalytic activity and
acyl group specificity for initiating their respective type
II polyketide biosynthetic processes [32–34]. These ob-
servations raise important and related questions: (1)
how are these specific initiation processes separate
from that catalyzed by the FAS FabH, and (2) in other
similar processes which initiate by a different mecha-
nism, why does the FAS FabH not appear to play a
role? The acyl carrier protein specificity of FabH and
FabH homologs appears to be an important factor in
this regard; the S. glaucescens FAS FabH has been
shown to be able to utilize a variety of FAS ACPs but
not ACPs encoded by polyketide biosynthetic pro-
cesses [16]. The FabH homolog ZhuG can utilize either
of the ACPs encoded by the R1128 polyketide biosyn-
thetic gene cluster and even discriminates between
them (the activity with a FAS ACP has not been re-
ported) [17].
The role of FabH initiating these biosynthetic pro-
cesses and determining the type of product made
makes it an attractive target for engineering production
of novel natural products. One approach to realize this
goal may be protein engineering of the substrate speci-
ficity of a PKS FabH. To this end, the crystal structure
of ZhuG has recently been determined [29]. We have
taken an alternative approach and successfully re-
placed a FabH-type enzyme from a natural product bio-
synthetic process with a FabH with different acyl speci-
ficity. In doing so, we have achieved the goal ofgenerating novel secondary metabolites. The strepto-
mycete FAS FabH represents an attractive choice for
the replacement enzyme, as an accumulation of evi-
dence has suggested it can utilize a broad array of
straight, branched, and cyclic acyl CoA substrates [19,
35]. The undecylprodiginine biosynthetic system was
chosen because the proposed pathway [3] suggested
that, with the exception of the elongation steps, FAS
enzymes catalyze formation of the dodecanoyl ACP in-
termediate. The ACP (encoded by redQ) in this process
was thus predicted to be a substrate for the S. coelico-
lor FAS enzymes as well as PKS enzymes (see Figure
1) and potentially more likely a substrate for the FAS
FabH than an ACP from an aromatic PKS [16].
Low-level production of prodiginines in the S. coeli-
color SJM1 mutant and the observation of novel
branched-chain alkylprodiginines suggested an ineffi-
cient initiation of prodiginine biosynthesis by the en-
dogenous FAS FabH. Supporting evidence is provided
by the increased production levels of prodiginines in
the same analog ratio with plasmid-based expression
of this enzyme. FabH-catalyzed elongation of the vari-
ous acyl CoA starter units using a malonyated RedQ is
proposed to give rise to these prodiginines (Figure 1).
(An alternative mechanism in which the FAS FabH uti-
lizes the FAS ACP and there is a crossover from the
fatty acid to the prodiginine biosynthetic process fur-
ther down the pathway cannot be ruled out.) A lower
catalytic efficiency with this RedQ substrate than corre-
sponding FabC (the FAS ACP) or low levels of the FAS
FabH at this stage of the fermentation [16] would con-
tribute to the observed decreased level of the process.
Indeed, FabH activity in SJM1 using malonylated RedQ
is decreased dramatically in cell extracts of the SJM1
mutant relative to the M511 and restored by plasmid-
based expression of the S. glaucescens FAS FabH. The
inability of the E. coli FAS FabH to significantly enhance
overall prodiginine levels in the SJM1 mutant may re-
flect low levels of expression of the enzyme and poten-
tially poor catalysis with the malonylated RedQ. Indeed,
our analyses of FabH activity levels in a fabH deletion
strain of S. coelicolor using the FAS ACP (FabC) show
much higher FabH levels from pSW7 than pSE4 (Y. Li,
G. Florova, and K.A.R., unpublished data). Nonetheless,
an apparent decrease in the ratio of the branched-chain
to straight-chain alkylprodiginines in the SJM1/pSE4
versus SJM1/pSE34 may indicate that the E. coli and
S. coelicolor FAS FabH compete to initiate the biosyn-
thetic process.
It is important and intriguing that, despite the fact
that the same enzyme initiates both processes, BCFAs
and straight-chain alkylprodiginines predominate in
S. coelicolor SJM1/pSW7. As these biosynthetic pro-
cesses do not occur simultaneously, changes in the
pools of the various acyl CoA precursors may account
for this observation. However, there are many examples
where significant levels of type I and type II polyketide
products are made from branched-chain acyl CoA sub-
strates [32, 36–39]. Alternatively, downstream enzymes
specific to each process might exhibit substrate speci-
ficities and could account for these observations. For
example, RedR (a FabF homolog) encoded by the pro-
diginine biosynthetic gene cluster may process straight-
chain acyl ACP substrates most efficiently, while the FAS
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198BFabF may exhibit greater efficiency with branched-chain
Lacyl ACP substrates. In this case, more efficient pro-
tduction of branched-chain alkylprodiginines relative to
b
the straight-chain analogs may require manipulation of T
the substrate specificity of RedR or other steps in the D
pprocess. Similar issues of substrate specificity of
mdownstream enzymes may also be valid for manipula-
stion of other polyketide and natural product pathways
7initiated by FabH homologs.
Substrate specificity may account for the observa- A
tion that methylbutyryl CoA and isobutyryl CoA appears T
to result only in two major new products, having two or r
one additional carbons, respectively. According to the c
mproposed pathway (Figure 1), these observations would
frequire the methylbutyryl CoA, isobutyryl CoA, and ace-
ptyl CoA primers to undergo a total of five, six, and six
G
elongation steps (using RedP/FabH and RedR) to make G
C13, C14, and C12 acyl ACP substrates, respectively. g
There thus appears to be some selectivity based on the P
3level of branching and chain length in the acyl ACP
gchain. For instance, a C12 acyl ACP derived from an
iisobutyryl CoA starter unit would be expected to give
l
rise to a methyldecylprodiginine with the same mass as (
the undecylprodigine. LC-MS analyses of prodiginines m
generated in SJM1/pSW7 with deuterated valine sug- 1
pgest that this product may be present, but only at very
alow levels, and not resolved from the undecylprodigi-
dnine. These observations may reflect acyl substrate
m
specificities in RedR, RedX (Figure 1), or enzymes cata- 1
lyzing later steps in the process. a
Significance A
T
bThis work has provided, to the best of our knowledge,
Mthe first example of using a FAS FabH to initiate a
n
complex natural product biosynthetic process, and a d
different approach for generating analogs of natural a
products. In principle, the approach demonstrated m
mherein may also be applied to other natural product
pathways that are initiated by FabH homologs and
nultimately even those which initiate by different
(
mechanisms. In this specific example, the use of a p
Streptomycetes FabH, able to use branched- and c
straight-chain acyl CoA substrates, has permitted the r
(production of novel prodiginines. The ratio of the pro-
wdiginine analogs is different from the ratio of pro-
ducts made by fatty acid biosynthesis, despite the
a
same enzyme initiating both processes. This observa- H
tion demonstrates that factors beyond the substrate m
specificity of the initiation enzyme also contribute to o
ethe determination of the final product ratio. To date,
mattempts to make novel prodiginine derivatives with
Wimproved activities have depended upon chemical
synthesis [2, 5]. The work described herein demon- C
strates that the cloning of the gene cluster and decod- C
ing of the pathway provide the basis for an additional f
and complementary rational bioengineering approach. p
b
rExperimental Procedures
e
gStrains and Culture Conditions
All E. coli strains and S. coelicolor used in this study were grown g
sfollowing standard protocols [40, 41]. The template plasmids and
strands used for PCR-targeted disruption (including E. coli fW25113, pIJ790, and pIJ773) were provided by Plant Biosciences
imited, Norwich, England and were developed Dr. Bertolt Gust at
he John Innes Center. The S. coelicolor cosmid 3F7 was provided
y Dr. Helen Kieser at the John Innes Center, Norwich, England.
he prodiginine-producer S. coelicolor M511 [42] was provided by
r. Greg Challis (University of Warwick, England). Determination of
rodiginine production was carried out by inoculating a baffled 500
l flask containing 100 ml of R2YE medium at pH 7.0 with 100 µl
pore suspension and incubating on an orbital shaker (170 rpm) for
days at 30°C.
llelic Replacement of redP in S. coelicolor
he redP gene of the prodiginine biosynthetic gene cluster was
eplaced with aac(3)IV resistance marker and oriT using the re-
ently developed PCR-targeted Streptomyces gene replacement
ethod [18]. The aac(3)IV resistance marker and oriT were ampli-
ied from the pIJ773 disruption cassette [18] using the following
rimer pairs: RedP-F1 5#-CACCGCACACCGCGGCCGCTCCGCGG
CGGTGCCCGGTGattccggggatccgtcgacc-3# and RedP-R1 5#-TCT
CGCGCGCTTCGGCCGGGCCCGGCCGGCCGCCCTCAtgtaggctg
agctgcttc-3# (pIJ773 homologous sequence is in lowercase). The
CR product was used to replace redP, first in S. coelicolor cosmid
F7, and then in S. coelicolor M511 following standard methodolo-
ies [18]. The resulting mutants were shown to be KanS, ApraR,
ndicating a double-crossover allelic exchange in S. coelicolor. Al-
elic replacement of the redP in the resulting mutant strain SJM1
redP::oriT, aac(3)IV) was confirmed by PCR amplification of chro-
osomal DNA using oligonucleotides which primed approximately
00 bp outside the region of recombination. The following primer
air was used: KOFabH-F 5#-ACTCCCCACACCTGCCGGGCC-3#
nd KOFabH-R 5#-CGGCGTCGCCGCCCATCCAG-3#. The pre-
icted 1.5 kb and 1.25 kb PCR products were obtained using chro-
osomal DNA from the SJM1 and M511 strains, respectively. The
.5 kb product from the SJM1 mutant was subsequently cloned
nd sequenced, confirming the allelic replacement of redP.
nalytical Methods
o measure cell growth, duplicate samples (10 ml) of fermentation
roth were collected every 24 hr, starting 48 hr after inoculation.
ycelia were collected on a preweighed filter (Whatman filter paper
o. 1) by vacuum filtration. The samples were washed twice with
istilled water, and the filters containing mycelia were dried at 80°C
nd weighed [43]. The overall prodiginine concentration was deter-
ined by absorbance at 530 nm (530 = 100, 500 M−1 cm−1) of a
ethanolic mycelia extract [44].
Determination of the relative abundances of the various prodigi-
ines was carried out by high-performance liquid chromatography
HPLC). The mycelia (1.0 g) were extracted with methanol, and the
rodiginines in a 10 µl sample were resolved with a Supelco Dis-
overy HS C18 column (4.6 × 250 mm) using a linear elution gradient
anging from CH3OH-CH3CN-H2O (40%:10%:50%) to CH3OH
100%) in 0.15% trifluoroacetic acid at a flow rate of 0.5 ml/min
ith detection at 530 nm [45].
The prodiginines were also resolved and identified by LC-MS
nalyses. LC-MS spectra (positive turbo-ion spray ionization mode;
PLC, Hewlett-Packard Series 1100; column, Luna C18 [4.6 by 250
m] from Phenomenex; mobile phase, as described above) were
btained on a Perkin-Elmer SCIEX API 2000 pneumatically assisted
lectrospray triple quadrapole mass spectrometer. High-resolution
ass spectrometry of the prodiginines was also carried out at the
ashington University Mass Spectrometry Resource.
omplementation of S. coelicolor SJM1
omplementation experiments with plasmids expressing three dif-
erent 3-ketoacyl ACP synthase III enzymes were carried out. The
lasmid pSW7 expressing the S. glaucescens fabH from PermE* has
een described previously and was generated by inserting the cor-
esponding fabH gene as a BglII fragment into the streptomyces
xpression plasmid pSE34 [22]. Similar approaches were used to
enerate the other two complementation plasmids. The E. coli fabH
ene was obtained as a BamHI PCR fragment using E. coli chromo-
omal DNA and inserted into pSE34 to create pSE4. The primer set
or this experiment was GAGAGAGGATCCACCCATGTATACGAA
Branched-Chain Alkylprodiginines in S. coelicolor
199GATTATTG (forward) and CTCTCTGGATCCTAGAAACGAACCAG
(reverse). The S. coelicolor redP was obtained as a BglII and SphI
PCR fragment from S. coelicolor cosmid 3F7 and cloned into the
BamHI-SphI sites of pSE34 to create pKR3. The primer set for this
experiment was CCGCACCAGATCTACCGCACACC (forward) and
CGGTCGTCTGCATGCGCTTCGG (reverse). Protoplasts of S. coe-
licolor SJM1 were prepared following standard methods and
transformed with pSW7, pSE4, and pKR3. The resulting thiostrep-
ton-resistant transformants were obtained, and their respective
prodiginine production levels were evaluated as described above.
DL-Valine Feeding Studies
Seed cultures of the S. coelicolor SJM1/pSE34 and SJM1/pSW7
were grown in R2YE media containing thiostrepton (12 µg/ml) for 3
days at 30°C and then used as a 5% inoculum for a 100 ml liquid
culture of the same media. Perdeuterated DL-valine (D8, 98%,
Cambridge Isotope Laboratories) was added to a final concentra-
tion of 20 mM at 48 hr. The production cultures were grown for 7
days at 30°C as described above. Mycelia were collected on filter
paper by vacuum filtration, washed twice with distilled water, and
then extracted with methanol for LC-MS analysis.
Determination of Relative FabH Activity Levels in Cell Extracts
Seed cultures of the S. coelicolor M511/pSE34, SJM1/pSE34,
SJM1/pSW7, SJM1/pSE4, and SJM1/pKR3 were grown in R2YE
media containing thiostrepton (12 µg/ml) for 2 days at 30°C. Wet
cells (1.0 g) from each fermentation were used to inoculate the
same media, which was subsequently fermented for 4 days at
30°C. Cells were collected by centrifugation at 5000 × g for 20 min
at 4°C, washed with 1× PBS buffer, resuspended in 5 ml buffer (50
mM Na+-phosphate [pH 7.5], 1 mM DTT, 1 mM PMSF, 5% glycerol),
and disrupted by sonication in an ice bath. Centrifugation at
20,000 × g for 20 min provided a cell extract, which was stored
at −80°C.
FabH activity in these cell extracts was determined using stan-
dard methodologies to monitor the conversion of radioactive acyl-
CoA and malonyl ACP substrates to a radiolabeled 3-ketoacyl-ACP
[46]. A standard reaction mixture contained the following compo-
nents in a final volume of 50 l: 100 mM sodium phosphate buffer
(pH 7.4), 10 g (total protein) of the cell extract, 200 M malonyl
ACP (Sigma), and 10 M [1-14C]acetyl-CoA (Moravek Biochemi-
cals, 50 Ci; specific activity, 50 mCi/mmol). The reaction was initi-
ated by adding [1-14C]acetyl-CoA and incubation at 30°C for 10
min. The reaction was terminated by addition of 10% trichloro-
acetic acid in the standard way [46].
Heterologous Expression and Purification
of the S. coelicolor redQ Gene
The redQ gene was PCR amplified using cosmid 3F7 as a template.
The forward primer (5#-GGCCCGCGCATATGAGCACCACCTACGA-
3#) contained an NdeI site (italicized). The reverse primer (5#-ATG-
CAGGATCCTCATGACGCGGTGGCCG-3#) contained a BamHI site
(italicized) 3# of the redQ stop codon. The PCR product was cloned
as an NdeI-BamHI fragment in pET15b (Novagen) to create pSJ1
and used to transform E. coli BL21(DE3) (Novagen). Expression of
redQ in the resulting ampicillin-resistant transformants was accom-
plished in LB fermentations (37°C) with IPTG (Sigma) induction
(1 mM) when the optical density at 600 nm of the culture reached
0.4–0.7. Cultures were incubated for 3 hr after induction, and cells
were collected by centrifugation at 20,000 × g for 10 min at 4°C.
Cells were lysed and the RedQ was purified by metal chelate chro-
matography by following the recommended procedures provided
by Novagen. Analysis of ACP purity was accomplished by electro-
phoresis with a 13% polyacrylamide gel containing 2.5 M urea in a
manner similar to that described previously [22].
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